학술논문

Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease
Document Type
Clinical report
Source
Biomarkers in Medicine. June 2011, Vol. 5 Issue 3, p377, 9 p.
Subject
Coronary heart disease -- Risk factors -- Diagnosis -- Development and progression
Low density lipoproteins -- Physiological aspects
Biological markers -- Usage
Atherosclerosis -- Complications and side effects
Health
Diagnosis
Complications and side effects
Physiological aspects
Usage
Development and progression
Risk factors
Language
English
ISSN
1752-0363
Abstract
Aims: Elevation of the leukocyte enzyme myeloperoxidase (MPO) in stable coronary artery disease (CAD) is controversial and its relationship with oxidized low-density lipoprotein (ox-LDL) and nitrite/nitrate (NOx) levels in CAD patients has not been evaluated. Therefore, we sought to evaluate these relationships. Materials & methods: This study included 50 stable CAD patients, 50 unstable CAD patients and 50 control subjects. Plasma MPO and ox-LDL levels were determined using enzyme immunoassay. Plasma NOx and other risk factors were also measured in the patients. Results: Plasma MPO levels were higher in unstable CAD patients (71.2 ± 19.6 ng/ml) than in stable CAD patients (34.5 ± 6.8 ng/ml) and control subjects (23.0 ± 3.6 ng/ml) (p < 0.001). Furthermore, plasma MPO was positively correlated with ox-LDL and negatively correlated with NOx levels (p < 0.05). Conclusion: Plasma MPO levels were elevated in CAD patients and its relation to CAD may be through the oxidation of LDL and reduction of NO levels.
Author(s): Saed Ziaaldin Samsamshariat [sup.1] , Gholam Basati [sup.[[dagger]]] [sup.3] , Ahmad Movahedian [sup.1] , Morteza Pourfarzam [sup.1] , Nizal Sarrafzadegan [sup.2] KEYWORDS : myeloperoxidase; stable CAD; unstable CAD Inflammation [...]